Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2024

Sep 9, 2024

30016_dirs_2024-09-09_256901ee-6278-45a0-a732-7b499bf66904.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2024-09-06

Reporting Person: AYERS JONATHAN W (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-09-06 Common Stock G 230000 Disposed 35651 Direct
2024-09-06 Common Stock G 302179 Disposed 0 Indirect
2024-09-06 Common Stock G 419574 Acquired 419574 Indirect
2024-09-06 Common Stock G 112605 Acquired 122605 Indirect

Footnotes

F1: The reporting person is the grantor and trustee of the Jonathan W. Ayers 2022 GRAT ('2022 GRAT'). The 2022 GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F2: The reporting person is the grantor and trustee of the Jonathan W. Ayers 2024 GRAT ('2024 GRAT'). The 2024 GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.